ABERRANT EXPRESSION OF IL-22RA1 ON HEMATOPOIETIC CELLS AS IMMUNOLOGICALLY SIGNATURE OF PRIMARY SJOGREN'S SYNDROME AND SJOGREN-ASSOCIATED NON-HODGKIN LYMPHOMAS

被引：0
|
作者：
Guggino, G. [1 ]
Ciccia, F. [1 ]
Rizzo, A.
Raimondo, S. [2 ]
Giardina, A. [1 ]
Carubbi, F. [3 ]
Cipriani, P. [1 ,3 ]
Sireci, G. [2 ]
Giacomelli, R. [3 ]
Alessandro, R. [2 ]
Triolo, G. [1 ]
机构：
[1] Univ Palermo, Dipartimento Biomed Med Interna & Specialist, Sez Reumatol Sperimentale, I-90133 Palermo, Italy
[2] Univ Palermo, Dipartimento Biopatol & Biotecnol Med & Forensi, Palermo, Italy
[3] Univ Aquila, Dipartimento Sci Clin Applicate & Biotecnol, I-67100 Laquila, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：77 / 78
页数：2
相关论文
共 50 条
  • [31] Gene expression profiling of epithelium-associated FcRL4+ B cells in primary Sjogren's syndrome reveals a pathogenic signature
    Verstappen, Gwenny M.
    Ice, John A.
    Bootsma, Hendrika
    Pringle, Sarah
    Haacke, Erlin A.
    de Lange, Kim
    van der Vries, Gerben B.
    Hickey, Peter
    Vissink, Arjan
    Spijkervet, Frederik K. L.
    Lessard, Christopher J.
    Kroese, Frans G. M.
    JOURNAL OF AUTOIMMUNITY, 2020, 109
  • [32] Risk of non-Hodgkin's lymphoma and thyroid cancer in primary Sjogren's syndrome measured using the Korean Health Insurance Claims Database
    Ahn, J. K.
    Hwang, J.
    Seo, G. H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (04) : S40 - S46
  • [33] Association between B Cell Growth Factors and Primary Sjogren's Syndrome-Related Autoantibodies in Patients with Non-Hodgkin's Lymphoma
    Xian, Zhenhua
    Fu, Dehua
    Liu, Shuang
    Yao, Yang
    Gao, Chun
    JOURNAL OF IMMUNOLOGY RESEARCH, 2019, 2019
  • [34] The risk of developing non-Hodgkin lymphoma and the mortality rate in primary Sjogren's syndrome: a single-centre, retrospective cohort study
    Mayer, Miroslav
    Martinic, Matea
    Reihl-Crnogaj, Mirna
    Anic, Branimir
    RHEUMATOLOGY INTERNATIONAL, 2023, 43 (11) : 2031 - 2036
  • [35] Combined therapy with rituximab plus cyclophosphamide/Vincristine/Prednisone for Sjogren's syndrome - associated B-Cell non-Hodgkin's lymphoma
    Carbone, J.
    Perez-Fernandez, R.
    Munoz, A.
    Sabin, P.
    Carreno, L.
    Fernandez-Cruz, E.
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2008, 34 (01) : 80 - 84
  • [36] RAG1 and 2 expression in the genesis of HIV associated non-Hodgkin's lymphomas (NHL)
    Levy, R
    Cayuela, JM
    Briere, J
    Biet, DI
    Sigaux, F
    Andrieu, JM
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 793 - 793
  • [37] Epratuzumab - Humanized anti-CD22 MAb non-Hodgkin's lymphoma therapy treatment of systemic lupus erythematosus treatment of Sjogren's syndrome
    Davies, SL
    Martin, L
    DRUGS OF THE FUTURE, 2005, 30 (07) : 683 - 687
  • [38] Combined Therapy with Rituximab Plus Cyclophosphamide/Vincristine/Prednisone for Sjogren’s Syndrome-Associated B-Cell Non-Hodgkin’s Lymphoma
    J. Carbone
    R. Perez-Fernandez
    A. Muñoz
    P. Sabin
    L. Carreño
    E. Fernandez-Cruz
    Clinical Reviews in Allergy & Immunology, 2008, 34 : 80 - 84
  • [39] Increased expression of IL-7 in labial salivary glands of patients with primary Sjogren's syndrome is associated with increased immunopathology
    Van Woerkom, J.
    Kruize, A. A.
    Wijk, M. Wenting-van
    Bijlsma, J. W. J.
    Lafeber, F. P. J. G.
    Van Roon, J. A. G.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 481 - 481
  • [40] Long term remission of Sjogren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone)
    Voulgarelis, M.
    Giannouli, S.
    Tzioufas, A. G.
    Moutsopoulos, H. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (08) : 1033 - 1037
12345